Last month, the Alliance for Innovation on Maternal Health (AIM) launched a new Patient Safety Bundle addressing perinatal mental health conditions. The current revision addresses gaps in the safety bundle previously released in 2016. Patient [...]
Eating disorders are common among women during the childbearing years; however, information on eating disorders in pregnant and postpartum women is relatively sparse.
This very helpful list from Wendy Davis, PhD, Executive Director of Postpartum Support International, describes what the various emergency services can provide.
Diagnosis of a mood or anxiety disorder during pregnancy was associated with a 3.5-fold increase in adverse perinatal outcomes.
Largest studies to date demonstrate statistically significant risk of preterm birth among women with active PTSD.
Peer support interventions can reduce the incidence of postpartum depression and the severity of depressive symptoms.
All of our information on the reproductive safety of medications comes from non-randomized studies. However, many of these studies fail to take into consideration other factors associated with maternal psychiatric illness which may also affect outcomes.
The use of valproic acid during pregnancy is associated with a significant increase in risk of major malformations and neurodevelopmental disorders. Given these risks, should it be a treatment option for women of childbearing age?
A recent review and meta-analysis found that upwards of 20% of women with no history of psychiatric illness experience their first bipolar-spectrum mood episode during the perinatal period.
Maternal ACEs were associated with both newborn amygdala volume and subsequent infant negative emotionality.
